Activated natural killer cell platform
The platform is described as having the capacity to destroy cancerous and virally infected cells.
Source: LinkedIn company description · Retrieved October 13, 2026
NantKwest is a clinical-stage immunotherapy company focused on using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases.
The company reports testing NK-cell safety and activity against a broad range of cancers in multiple phase 1 clinical trials in the United States, Canada, and Europe.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The platform is described as having the capacity to destroy cancerous and virally infected cells.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.